Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Other financing activities of $1.3 million in Q1 2026, up 65500.0% quarter-over-quarter from $2000.0 in Q1 2025, and up 65500.0% on a YoY basis from N/an in Q1 2025.
Scholar Rock Holding (SRRK) Other financing activities (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Other financing activities history runs 7 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Other financing activities rose 65500.0% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 43700.0% YoY), while the FY2023 annual figure was $3000.0, changed N/A from the prior year.
- Other financing activities was $1.3 million for Q1 2026 at Scholar Rock Holding, up from $2000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.3 million in Q1 2026 to a low of $1000.0 in Q2 2023.
- Historically, Other financing activities has averaged $329250.0 across 3 years, with a median of $2000.0 in 2023.
- Biggest YoY gain for Other financing activities was 65500.0% in 2026; the steepest drop was 65500.0% in 2026.
- A 3-year view of Other financing activities shows it stood at $1000.0 in 2023, then soared by 100.0% to $2000.0 in 2025, then jumped by 65500.0% to $1.3 million in 2026.
- The last three Other financing activities figures came in at $1.3 million (Q1 2026), $2000.0 (Q1 2025), and $1000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Sep 30, 2021 | -9,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Mar 31, 2021 | -6,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Dec 31, 2020 | -4,000.00 |
| Sep 30, 2020 | -6,000.00 |
| Sep 30, 2020 | -6,000.00 |